论文部分内容阅读
时间对于急性缺血性脑卒中患者至关重要,可直接影响患者的治疗效果及预后效果,发病4.5 h以内给予重组组织型纤溶酶原激活剂静脉溶栓治疗是目前脑血管病指南一致推荐的治疗方案,溶栓越早,开通堵塞血管越快,救治效果越好,可显著减少残疾及改善预后。时间窗是关键,要提高溶栓率,就要缩短患者从发病到接受溶栓治疗的时间。因此,研究目前急性缺血性脑卒中治疗现状,研究脑卒中患者救治过程中相关的院前和院内的延误原因,针对延误原因采取干预措施,有助于建设和规范急性缺血性脑卒中患者发病后连贯的急救救治流程,实现院前、院内的无缝链接达到一体化救治,减少延误时间,加快急救速度,提高溶栓率,提高治疗效果,降低疾病致残率和致死率。
Time is critical for patients with acute ischemic stroke, which can directly affect the therapeutic effect and prognosis of patients. Intravenous thrombolysis with recombinant tissue plasminogen activator within 4.5 hours of onset is the guideline of cerebrovascular disease Of the treatment options, the earlier the thrombolysis, the faster the occlusion of blood vessels, the better the treatment effect, can significantly reduce disability and improve prognosis. Time window is the key, to improve the rate of thrombolysis, it is necessary to shorten the patient from onset to receive thrombolytic therapy time. Therefore, the study of the current status of the treatment of acute ischemic stroke, the study of stroke patients in the treatment of pre-hospital and hospital-related causes of delay, to delay the cause of interventions to help build and regulate acute ischemic stroke patients After the onset of coherent first aid treatment process, to achieve prehospital, hospital seamless link to achieve an integrated treatment to reduce the delay time, speed up the emergency treatment, increase the rate of thrombolysis, improve the therapeutic effect, reduce morbidity and mortality.